Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.44 by 11.36 percent. This is a 11.36 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $197.913 million which beat the analyst consensus estimate of $192.907 million by 2.60 percent. This is a 18.12 percent increase over sales of $167.547 million the same period last year.